Descriptor: "*METASTATIC breast cancer" / Journal: value in health / Topic: breast - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"*METASTATIC breast cancer"' showing total 8 results

Start Over Descriptor "*METASTATIC breast cancer" Topic breast Journal value in health

8 results on '"*METASTATIC breast cancer"'

1. SA21 Feasibility Assessment of an Indirect Treatment Comparison (ITC) of Sacituzumab Govitecan (SG) Vs Trastuzumab Deruxtecan (T-DxD) in HR+/HER2– Metastatic Breast Cancer (mBC).

Author: Shah, A., Thaliffdeen, R., Proudman, D., Verret, W., Sjekloca, N., and Campone, M.
Subjects: *METASTATIC breast cancer, *BREAST, *TRASTUZUMAB
Published: 2023
Full Text: View/download PDF

2. CO119 Clinical Utility of Circulating Tumor Cell Enumeration-Based Liquid Biopsy in Patients with Metastatic Breast Cancer: A Review of the Peer-Reviewed Clinical Literature.

Author: Cristofanilli, M., de Snoo, F., Stork-Sloots, L., Hansen, T., Garay, C.A., Lazaro, S., Chabut, D., Picardo, F., Simonelli, C., Kuhr, F., and Spinner, D.
Subjects: *METASTATIC breast cancer, *BIOPSY, *LIQUIDS, *BREAST
Published: 2023
Full Text: View/download PDF

3. EE291 Economic Evaluation of Metastatic Breast Cancer Following Trastuzumab-Based Treatment of HER2+ Early Breast Cancer in Hong Kong.

Author: Li, JTS, Cheng, F, and Lee, V
Subjects: *HER2 positive breast cancer, *METASTATIC breast cancer, *TRASTUZUMAB, *BREAST
Published: 2022
Full Text: View/download PDF

4. EE213 Cost-Effectiveness Analysis of Trastuzumab Deruxtecan for Patients With HER2+ Metastatic Breast Cancer.

Author: Mudumba, R, Chan, H, Cheng, YY, Wang, CC, Correia, L, Ballreich, J, and Levy, J
Subjects: *HER2 positive breast cancer, *METASTATIC breast cancer, *TRASTUZUMAB, *COST effectiveness, *BREAST
Published: 2022
Full Text: View/download PDF

5. PCN79 IMPACT of Adjuvant Trastuzumab Emtansine (T-DM1) on the Incidence of HER2-Positive Metastatic Breast Cancer and Its Associated Savings for the Spanish National Healthcare System.

Author: Martín, M., Albanell, J., Moreno, E., Costa-Samarra, J., Arroyo, I., and Colomer, R.
Subjects: *METASTATIC breast cancer, *HER2 positive breast cancer, *TRASTUZUMAB, *BREAST, *MEDICAL care
Published: 2020
Full Text: View/download PDF

6. PCN69 Cost-Effectiveness Analysis of NOVEL Therapies for HER2+ Metastatic Breast Cancer: [FAM-] Trastuzumab Deruxtecan Versus Tucatinib Trastuzumab and Capecitabine Combination.

Author: Vondeling, G., Palaka, E., Livings, C., Naik, J., and Sullivan, W.
Subjects: *HER2 positive breast cancer, *METASTATIC breast cancer, *TRASTUZUMAB, *COST effectiveness, *BREAST
Published: 2020
Full Text: View/download PDF

7. PCN310 Real World Burden and Impact of Brain Metastases on Quality of Life and Healthcare Resource Utilization Among Metastatic Breast Cancer Patients.

Author: Ike, C., Pike, J., Lewis, K., Bailey, A., and DeBusk, K.
Subjects: *METASTATIC breast cancer, *CANCER patients, *QUALITY of life, *BREAST, *MEDICAL care
Published: 2020
Full Text: View/download PDF

8. PCN104 Cost-Utility MODEL of Trastuzumab Emtansine (T-DM1) in HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer Previously Treated with Trastuzumab and a Taxane, Compared with Capecitabine PLUS Lapatinib, Trastuzumab PLUS Capecitabine and Capecitabine ALONE in Turkey

Author: Akyol Ersoy, B., Erdogan-Ciftci, E., Yanik, L., Guler, B., Ozcan, G., and Paracha, N.
Subjects: *METASTATIC breast cancer, *BREAST, *LAPATINIB, *TRASTUZUMAB
Published: 2020
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results